BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1323594)

  • 1. The use of antimycobacterial agents in Crohn's disease.
    Thayer WR
    J Clin Gastroenterol; 1992 Jul; 15(1):5-7. PubMed ID: 1323594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evidence for Mycobacterium paratuberculosis in Crohn's disease.
    Behr MA; Kapur V
    Curr Opin Gastroenterol; 2008 Jan; 24(1):17-21. PubMed ID: 18043227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifabutin and ethambutol do not help recurrent Crohn's disease in the neoterminal ileum.
    Rutgeerts P; Geboes K; Vantrappen G; Van Isveldt J; Peeters M; Penninckx F; Hiele M
    J Clin Gastroenterol; 1992 Jul; 15(1):24-8. PubMed ID: 1323593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticum DNA cannot be detected by PCR in Crohn's disease tissue.
    Cellier C; De Beenhouwer H; Berger A; Penna C; Carbonnel F; Parc R; Cugnenc PH; Le Quintrec Y; Gendre JP; Barbier JP; Portaels F
    Gastroenterol Clin Biol; 1998; 22(8-9):675-8. PubMed ID: 9823555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
    Prantera C; Kohn A; Mangiarotti R; Andreoli A; Luzi C
    Am J Gastroenterol; 1994 Apr; 89(4):513-8. PubMed ID: 8147352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycobacterial therapy in Crohn's disease: game over?
    Peyrin-Biroulet L; Neut C; Colombel JF
    Gastroenterology; 2007 Jun; 132(7):2594-8. PubMed ID: 17570230
    [No Abstract]   [Full Text] [Related]  

  • 8. The causation of Crohn's disease and treatment with antimicrobial drugs.
    Hermon-Taylor J
    Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):607-10. PubMed ID: 10076782
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of the Australian Crohn's disease antibiotic study.
    Chamberlin W
    Gastroenterology; 2007 Nov; 133(5):1744-5; author reply 1745-6. PubMed ID: 17983827
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection and Isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia.
    Sechi LA; Scanu AM; Molicotti P; Cannas S; Mura M; Dettori G; Fadda G; Zanetti S
    Am J Gastroenterol; 2005 Jul; 100(7):1529-36. PubMed ID: 15984976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paratuberculose enteritis and Crohn's disease].
    Suárez Fernández G
    An R Acad Nac Med (Madr); 2007; 124(2):221-34; discussion 234-40. PubMed ID: 18069597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study.
    Kuenstner JT
    Gastroenterology; 2007 Nov; 133(5):1742-3; author reply 1745-6. PubMed ID: 17983824
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
    Borody TJ; Leis S; Warren EF; Surace R
    Dig Liver Dis; 2002 Jan; 34(1):29-38. PubMed ID: 11926571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium avium subspecies paratuberculosis and Crohn's disease granulomas.
    Toracchio S; El-Zimaity HM; Urmacher C; Katz S; Graham DY
    Scand J Gastroenterol; 2008; 43(9):1108-11. PubMed ID: 18609156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australian Crohn's antibiotic study opens new horizons.
    Gitlin L; Biesecker J
    Gastroenterology; 2007 Nov; 133(5):1743-4; author reply 1745-6. PubMed ID: 17983826
    [No Abstract]   [Full Text] [Related]  

  • 16. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease.
    Shafran I; Kugler L; El-Zaatari FA; Naser SA; Sandoval J
    Dig Liver Dis; 2002 Jan; 34(1):22-8. PubMed ID: 11930899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars.
    Borody TJ; Bilkey S; Wettstein AR; Leis S; Pang G; Tye S
    Dig Liver Dis; 2007 May; 39(5):438-44. PubMed ID: 17369114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The etiology of Mycobacterium avium subspecies paratuberculosis in Crohn's disease.
    Alluwaimi AM
    Saudi Med J; 2007 Oct; 28(10):1479-84. PubMed ID: 17914503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
    Prantera C; Scribano ML
    Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.